DOCSLIB.ORG

NHS Education for Scotland Boardpaper Summary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NHS Education for Scotland Boardpaper Summary NES NES/16/21 Item 8a (Enclosure) March 2016 NHS Education for Scotland BoardPaper Summary 1. Title of Paper Strategic Developments in NHSScotland - Consideration of recent publications of strategic importance: The National Clinical Strategy; the Chief Medical Officers Annual Report, ‘Realistic Medicine’; and the Review of Public Health in Scotland. 2. Author(s) of Paper Caroline Lamb, Chief Executive 3. Purpose of Paper To allow the Board an opportunity to consider and discuss the implications of these reports. 4. Key Issues The last 6 weeks have seen the publication of three documents which are of strategic importance for NHS Scotland. These are: The National Clinical Strategy – Launched in February 2016, this strategy highlights the significant changes in Scotland’s population and in the needs and demands placed on our health and social care services. It makes proposals for how clinical services need to change in order to provide sustainable health and social care services fit for the future. The Chief Medical Officers (CMO) Annual Report – ‘Realistic Medicine’, published in January 2016, sets out to begin a discussion on some of the fundamental principles of how medicine is practiced today and how doctors can be hugely influential in improving care. The Review of Public Health in Scotland – Also published in February 2016 this report draws attention to the complex and persistent public health challenges and makes a number of recommendations in relation to achieving a more strategic and coherent approach to public health. 5. Educational Implications All these publications have important strategic implications for the future shape and direction of NHS Scotland. The National Clinical Strategy, along with the Review of Public Health and the Health and Social Care agenda are being described as the major ‘game changers’ in relation to moving to a different vision of the delivery of health and social care. 1 6. Financial Implications None yet quantified for NES 7. Which of the 9 Strategic Outcome(s) does this align to? This paper is presented to allow the Board an opportunity to discuss important developments in the strategic context in which we work. 8. Impact on the Quality Ambitions The publications highlighted in this report are designed to deliver on all of the quality ambitions 9. Key Risks and Proposals to Mitigate the Risks It is important that the Board maintain an awareness of developments in this areas so that we can ensure an appropriate strategic response. 10. Equality and Diversity These publications have a strong focus on reducing inequalities. 11. Communications Plan These are Scottish Government publications and communications have been handled accordingly 12. Recommendation(s) for Decision The Board is recommended to consider and comment on these publications. NES March 2016 CSL 2 A NATIONAL CLINICAL STRATEGY FOR SCOTLAND The Scottish Government February 2016 A NATIONAL CLINICAL STRATEGY FOR SCOTLAND CONTENTS 02 Foreword 04 Preface 06 1. Executive Summary 14 2. Introduction: Why do we need to change? 16 a. Demographic changes in our population 19 b. The changing patterns of illness and disability 23 c. The relatively poor health of the population and persisting inequalities in health 25 d. The need to balance health and social care according to need 27 e. Workforce issues 33 f. Financial considerations 35 g. Changes in the range of possible medical treatments 36 h. Remote and rural challenges to high quality healthcare 38 i. Opportunities from increasing information technology (e-health) 41 j. A need to reduce waste, harm and variation in treatment 44 3. Primary and Community Care 61 4. Secondary and Tertiary Care 77 5. The need for “realistic” medicine 85 6. Conclusion 01 A NATIONAL CLINICAL STRATEGY FOR SCOTLAND FOREWORD Over the last ten years there have been significant changes in Scotland’s population and in the needs and demands placed on our health and social care services. In 2010, in the Quality Strategy, the Scottish Government set out its strategic vision for achieving sustainable quality in the delivery of healthcare services across Scotland, in the face of the significant challenges of Scotland’s public health record, our changing demography and the economic environment. In 2011, the Scottish Government committed to integrating health and social care, to address in particular the changing needs of our growing population of people with multiple complex needs, many of whom are older. This was followed in 2012 by publication of the 2020 Vision which provided the strategic narrative and context for taking forward integration and implementing the Quality Strategy, and the required actions to improve efficiency and achieve financial sustainability. In 2015 the Scottish Government set out • Developments should be guided by the need for transformational change in evidence where available: evaluation NHSScotland to meet people’s health and of any changes should be considered social care needs by 2020 and beyond. The before making the changes. Scottish Government’s Draft Budget for • We will continue to provide caring health 2016/17 proposes significant new investment and social care services that will recognise in health and social care services to pursue the central importance of the role of ambitious reform. This National Clinical people using services, their carers, and Strategy is an important contribution to their community in providing support. This the provision of clarity on the priorities for allows people and communities to manage that reform. The Strategy is underpinned their own health more. A system that by the following set of key principles: seeks to build on this, rather than supply alternatives, is likely to improve population • Quality must be the primary concern – health and wellbeing, as well as the all developments should seek to ensure individual experience and outcome of illness. that there is enhancement of patient safety, clinical effectiveness and a • Services will be based around supporting person-centred approach to care. people, rather than single disease pathways, with a solid foundation of integrated health and social care services based on new models of community-based provision. 02 • Where clinically appropriate we will Scotland has a long tradition of providing continue to plan and deliver services at a high quality health and social care local level. Where there is evidence that services to our population and we believe better outcomes could only be reliably that we are well placed to achieve the and sustainably produced by planning transformational change required. services on a regional or national level, we will respond to this evidence to There has been extensive engagement with secure the best possible outcomes. clinicians, professionals and stakeholders in • The impact of health inequalities will the preparation of this draft of the National be minimised by ensuring equitable Clinical Strategy. However, we recognise it’s access to health and social care not the finished article and that we need support, removing barriers that make to engage further about it. The national people less likely to access care. conversation on “Creating a Healthier Scotland” provides the ideal opportunity for The Strategy makes proposals for how that engagement. So we will, through the clinical services need to change in national conversation, engage with those order to provide sustainable health and interests but also with the public whom social care services fit for the future. It health and social care services serve. sets out a vision that is both ambitious and challenging as a basis for further engagement with clinicians and the public. Professor Jason Leitch Dr Catherine Calderwood Professor Fiona McQueen National Clinical Director Chief Medical Officer Chief Nursing Officer 03 A NATIONAL CLINICAL STRATEGY FOR SCOTLAND PREFACE At the beginning of 2015 Ministers decided The National Clinical Strategy has been built that it was appropriate to draft a National on a process of reviewing written evidence on Clinical Strategy that would develop further the organisation of healthcare, and seeking the 2020 Vision, and look towards a longer contributions and comments from a wide time scale, up to 2025-30. The National range of stakeholders, from within Government, Clinical Strategy would lay out a framework and from the wider NHS in Scotland. that would take account of several significant changes in Scotland, including the changing The National Clinical Strategy is, by necessity, demographic composition of our population, both high-level and strategic, and seeks to set the increased demand for health and social out a broad direction for change to help the care that will follow the advent of Health NHS in Scotland meet the challenges ahead, and Social Care Integration, and significant with its partners in local government and the technological changes in healthcare. third and independent sectors, who provide social care services. The development of the This Strategy has been developed by a small Strategy has taken place at a time when there team (Dr Angus Cameron, Elizabeth Porterfield are a large number of other reviews ongoing and Karen MacNee) who have been led and such as the Reviews of Public Health and of supported by an oversight group drawn GP Out of Hours Services. In addition there from across the service, and consisting of: are a number of NHS Boards reviewing their strategic plans, particularly in the context of National Clinical Director: development of Integration Joint Boards. The Professor Jason Leitch Strategy seeks to give a fresh perspective Chief Medical Officer: to these reviews and strategic plans to help Dr Catherine Calderwood a more uniform approach to future change Chief Nursing Officer: Fiona McQueen that is coherent across the whole system. Finance Director: John Matheson NHS Board Chief Executives: Robert In developing the strategy, care has been Calderwood, Cathie Cowan, John taken to engage with a wide variety of Turner (until July 2015), Jill Young staff across Scottish Government and NHS Boards, with a particular focus on clinicians NHS Board Chairpersons: Lindsay Burley, and their representatives.
Load more

Recommended publications
  • Ppc/S5/16/4/A Public Petitions Committee
    PPC/S5/16/4/A PUBLIC PETITIONS COMMITTEE AGENDA 4th Meeting, 2016 (Session 5) Thursday 29 September 2016 The Committee will meet at 9.30 am in the Mary Fairfax Somerville Room (CR2). 1. Consideration of continued petitions: The Committee will consider- PE1223 by Ron Beaty on school bus safety; PE1319 by William Smith and Scott Robertson on improving youth football in Scotland; PE1408 by Andrea MacArthur on updating of pernicious anaemia/vitamin B12 deficiency understanding and treatment; PE1458 by Peter Cherbi on register of interests for members of Scotland’s judiciary; PE1463 by Sandra Whyte, Marian Dyer and Lorraine Cleaver on effective thyroid and adrenal testing, diagnosis and treatment; PE1480 by Amanda Kopel, on behalf of The Frank Kopel Alzheimer's Awareness Campaign, on alzheimer’s and dementia awareness and PE1533 by Jeff Adamson, on behalf of Scotland Against the Care Tax, on abolition of non-residential social care charges for older and disabled people; PE1517 by Elaine Holmes and Olive McIlroy, on behalf of Scottish Mesh Survivors - Hear Our Voice campaign, on polypropylene mesh medical devices; PE1540 by Douglas Philand on permanent solution for the A83; PE1545 by Ann Maxwell, on behalf of Muir Maxwell Trust, on residential care provision for the severely learning disabled; PE1563 by Doreen Goldie, on behalf of Avonbridge and Standburn Community Council, on sewage sludge spreading; PE1568 by Catherine Hughes on funding, access and promotion of the NHS CIC; PE1577 by Rachael Wallace on adult cerebral palsy services; PE1581
    [Show full text]
  • [email protected]
    ANNEX A Document reference: 1 From: Calderwood C (Catherine) [[email protected]] Sent: 06 March 2020 10:08 To: Lloyd E (Elizabeth) <[email protected]>; SG CoronaVirus <[email protected]>; Cabinet Secretary for Health and Sport <[email protected]> Cc First Minister <[email protected]>; Minister for Public Health, Sport and Wellbeing <[email protected]>; Minister for Mental Health <[email protected]>; DG Health & Social Care <[email protected]>; Hutchison D (David) <[email protected]>; SGoRR Major Events <[email protected]>; Wright M (Malcolm) <[email protected]>; Permanent Secretary <[email protected]>; [redacted] <[email protected]>; redacted <[email protected]>; Smith G (Gregor) <[email protected]>; redacted <[email protected]>; redacted <[email protected]>; Foggo R (Richard) <[email protected]>; redacted <[email protected]>; redacted <[email protected]>; redacted <redacted @gov.scot>; redacted <[email protected]>; redacted <[email protected]>; redacted <[email protected]>; redacted <[email protected]>; McAllan M (Màiri) (Special Adviser) <[email protected]> Subject: RE: Thursday 5 March - New Cases This is an international effort. 71 people from many countries attended a conference organised by NIKE in Edinburgh 25-27th February. There are now 8 cases in the UK linked to this conference -3 in Scotland, 3 England, 1 NI. NIKE contacted all attendees after a positive case was confirmed and they have all been monitoring their health and the now positive cases came forward to be tested when they developed symptoms. There is an international effort on contact tracing which is still ongoing- PHE and PHA also involved. There is some sensitivity internationally about the index case- which people were or were not symptomatic at the time of the conference – this is still ongoing.
    [Show full text]
  • Vaginal Surgery and Urogvnecologv, LLC Dionysios K
    Letter from Dr Veronikis to Cabinet Secretary Jeane Freeman dated 8 April 2019. Vaginal Surgery and Urogvnecologv, LLC Dionysios K. Veronikis, M.D. Urogynecology Reconstructive Pelvic Surgery Advanced Gynecologic Surgery 8 April, 2019 Dear Cabinet Secretary Freeman, I hope this letter finds you well. I am aware of the March senate debate on my extended offer and willingness to help mesh injured women in Scotland. As you have acknowledged, I noted in your statement, that you had not yet been contacted directly. I apologize as I did not think to reach out to you directly. It was my understanding that Mr. Findlay MSP had communicated the requirement for an invitation to Scotland on the basis of the GMC approved Eminent Visiting Surgeon pathway. Today, I would like to confirm in principle my willingness to come to Scotland and to help the mesh injured patients. My focus is to help address the backlog of women waiting in the public health system for surgical treatment. I am experienced in the most complex presentations of mesh injury. I would 'welcome an invitation from the Scottish government and its clinical community as the first step necessary to engage in the GMC process. I thank you for your willingness to engage further and I am happy to arrange a telephone call at a mutually convenient time. Yours sincerely [REDACTED] Dionysios K. Veronikis, MD, FACOG, FACS Mercy Doctors’ Building, Tower B, Suite 2002, 621 South New Ballas Road, St. Louis, Missouri 63141 Tel: (314) 251-6753 Fax: (314) 251-4492 Exchange: (314) 868-7700 Letter from Cabinet Secretary Jeane Freeman to Dr Veronikis in response to his letter dated 8 April 2019.
    [Show full text]
  • Conference Programme
    World Health Organization International Healthy Cities Conference 1 – 4 October 2018, Waterfront, Belfast, Northern Ireland Changing cities to change the world Celebrating 30 years of the Healthy Cities movement Programme - Programme is subject to change 1 Sunday 30 September 2018 19.00 Sunday 30 September 2018 19.00 – 21.00: Registration, Waterfront Hall, Riverside Entrance Monday 1 October 2018 7.00 Monday 1 October 2018 7.00 – 9.00: Registration, Waterfront Hall, Riverside Entrance Music by Blackthorn 8.30 Monday 1 October Conference Chair: Monika Kosinska, Programme Manager, Division of Policy and Governance for Health and Well- being, WHO Regional Office for Europe Master of Ceremonies: Brendan Mulgrew 8.30–10.00: Business meeting: WHO European Healthy Cities business meeting Belfast Waterfront, Auditorium Russian, Spanish and Turkish translation available Welcome opening: Kate Nicholl, Councillor, Chair, People & Communities Committee, Belfast Co-Chair: Monika Kosinska, Programme Manager, Division of Policy and Governance for Health and Well-being, WHO Regional Office for Europe Co-Chair: David Stewart, Chair, Belfast Healthy Cities Close of Phase VI and preparation for Phase VII of the WHO European Healthy Cities Network (Open to all delegates; voting restricted to members of the WHO European Healthy Cities Network in Phase VI) 10.00 Monday 1 October 10.00–12.30: Side event Delegates will leave Belfast Waterfront, city side entrance at 10.00am to travel to Side Events. Delegates not attending the Business meeting should go directly to their chosen Side Event venue. Refreshments will be available on arrival at each side event 10.30 Monday 1 October 10.30 – 12.30: Side Events 1.
    [Show full text]
  • The Behavioural Economics of Government Responses to COVID-19
    Journal of Behavioral Economics for Policy, Vol. 4, COVID-19 Special Issue 3, 11-43, 2020 The behavioural economics of government responses to COVID-19 Gigi Foster1* Abstract How have governments around the world responded to the novel coronavirus first discovered in China’s Wuhan province in late 2019 (the cause of COVID-19 disease)? What has driven governments’ responses, and to what extent can behavioural economics help us to understand the policies that have been enacted? In this short paper I examine the responses of four countries, mapped against media reporting, local context and viral spread, and discuss how core behavioural economics insights can illuminate the possible reasons for those responses. The paper concludes with observations about how these insights can be used for good by governments – in predicting public reactions, and in setting and selling government policy – the next time that the world faces a pandemic. JEL Classification: H12; I18; Z18 Keywords COVID-19 — fear — media — salience — reference dependence 1UNSW Business School, University of New South Wales, Sydney, Australia *Corresponding author: [email protected] Introduction review a suite of well-documented behavioural phenomena and outline how each of them may have played a role in gener- The world has been shaken by the COVID-19 pandemic in ating the public sentiment and subsequent political responses a way unlike what we have seen in any prior global health we have seen. Part 3 concludes with a set of lessons from the event. What started as a local health anomaly in one Chinese experience that humanity can take to its next confrontation province quickly became a world-stopping crisis affecting with a contagious global health threat.
    [Show full text]
  • Nhs Education for Scotland Framework Document Scottish Government
    NHS Education for Scotland NES/21/40 AGENDA FOR THE ONE HUNDRED AND SIXTY-SECOND BOARD MEETING Date: Thursday 27 May 2021 Time: 10.15 – 11.38 Venue: In response to the COVID-19 pandemic and public health protection measures, this meeting will be held remotely using Microsoft Teams 1. 10.15 Chair’s introductory remarks 2. 10.15 Apologies for absence 3. 10.16 Declarations of interest 4. 10.16 Minutes of the One Hundred and Sixty-First Board Meeting NES/21/41 11 February 2021 For Approval 5. 10.18 Matters arising from the Minutes and notification of Any Other Business 6. 10.18 Actions from previous Board Meetings NES/21/42 For review 7. 10.23 Chair and Chief Executive reports a. 10.23 Chair’s Report (verbal report) b. 10.33 Chief Executive’s Report NES/21/43 8. Performance Items a. 10:55 Risk Register Report NES/21/44 For Assurance and Approval (A. McColl) b. 11.05 2020/21 Quarter 4 Performance Report NES/21/45 For Assurance and Approval (D. Cameron) 9. Annual Items None 1 10. Governance Items a. Significant issues to report from Standing Committees: - 11.20 Audit and Risk Committee held 29 April 2021 (D. Steele, verbal update) - 11.25 Staff Governance Committee held 06 May 2021 (L. Dunion, verbal update) b. 11.30 Board Standing Orders NES/21/46 For Approval (D. Thomas) 11. Items for Noting 11.35 Standing Committee Minutes a. Audit and Risk Committee 28 January 2021 NES/21/47 For Noting b. Staff Governance Committee 04 February 2021 NES/21/48 For Noting 11.35 Other items for noting c.
    [Show full text]
  • Business Interruption Insurance Test Case: Agreed Facts 1
    CLAIM NO: FL-2020-000018 IN THE HIGH COURT OF JUSTICE BUSINESS AND PROPERTY COURTS COMMERCIAL COURT (QBD) FINANCIAL LIST FINANCIAL MARKETS TEST CASE SCHEME BETWEEN THE FINANCIAL CONDUCT AUTHORITY Claimant -and- (1) ARCH INSURANCE (UK) LIMITED (2) ARGENTA SYNDICATE MANAGEMENT LIMITED (3) ECCLESIASTICAL INSURANCE OFFICE PLC (4) HISCOX INSURANCE COMPANY LIMITED (5) MS AMLIN UNDERWRITING LIMITED (6) QBE UK LIMITED (7) ROYAL & SUN ALLIANCE INSURANCE PLC (8) ZURICH INSURANCE PLC Defendants ___________________________________ AGREED FACTS – DOCUMENT 1 CHRONOLOGY OF GOVERNMENT RESPONSE TO COVID-19 IN THE UK ____________________________________ 11/62475632_2 1 Date Event1 Detail2 Source Page Reference 1. 31 Dec 19 WHO informed of https://www.who.int/csr/don/05- 1-2 cases of january-2020-pneumonia-of-unkown- pneumonia of cause-china/en/ unknown cause in Wuhan, Hubei, China 2. 22 Jan 20 UK DHSC and Statement from the Department of Health and Social Care (“DHSC”) and https://www.gov.uk/government/news/ 3-4 PHE raise risk Public Health England (“PHE”): dhsc-and-phe-statement-on- level to UK from “We have been carefully monitoring the coronavirus situation in Wuhan and coronavirus ‘very low’ to ‘low’ are ready to put in place proportionate, precautionary measures. From today, enhanced monitoring will be in place from all direct flights from Wuhan to the UK.… The risk to the UK population has been assessed as low, based on the emerging evidence regarding case numbers, potential sources and human to human transmission. This has been raised from very low due to evidence on the likelihood of cases being imported into this country.
    [Show full text]
  • First Do No Harm
    First Do No Harm The report of the Independent Medicines and Medical Devices Safety Review © Crown copyright 2020 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at www.gov.uk/official-documents. Publication date: 8 July 2020 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group First Do No Harm – The report of the Independent Medicines and Medical Devices Safety Review Letter to the Secretary of State from Baroness Cumberlege 8th July 2020 Dear Secretary of State I publish this report at a time when the NHS has been facing enormous challenges arising from the Covid-19 pandemic. NHS staff have risen to those challenges, proving day after day their ability to provide excellent care often in the most testing of circumstances. All of us have, quite literally, applauded them for their tireless commitment. This Review, however, has been about people who have suffered avoidable harm. Our report is entitled “First Do No Harm”. Having spent two years listening to heart wrenching stories of acute suffering, families fractured, children harmed and much else, I and my team thought it an appropriate title. It is a phrase that should serve as a guiding principle, and the starting point, not only for doctors but for all the other component parts of our healthcare system.
    [Show full text]
  • Community-Led Responses to COVID-19 Are a Matter of Urgency in Syria, Write Lisa Boden, Ann-Christin Wagner, Shaher Abdullateef and Anas Al Kaddour
    Community-led responses to COVID-19 are a matter of urgency in Syria, write Lisa Boden, Ann-Christin Wagner, Shaher Abdullateef and Anas Al Kaddour People living in the Global North might argue that the coronavirus pandemic (COVID-19) is the greatest existential threat to life as we know it in the last 100 years. Yet for Syrians, the pandemic, while undeniably traumatic, is just one more event in a litany of equally-devastating hardships that have proven inescapable, difficult and necessary to endure. Years of protracted conflict mean that Syrians have become inured to living with significant risks and uncertainties about their future lives and livelihoods. While the attention and resources of apparent former ‘global health powerhouses’ like the UK and USA, are fixed on solving challenges posed by disease transmission and constraints on healthcare systems in their own countries, there is a growing danger that the impacts of disease incursion on displaced and vulnerable populations in fragile and conflict-affected states may be completely neglected. In countries everywhere, ensuring access to appropriate healthcare is the immediate priority in this outbreak. But in countries like Syria, effective solutions are also needed to support other types of life-sustaining interventions, such as local and cross-border distribution of food and agricultural inputs which facilitate labour, militate loss of income and prevent food insecurity and its attendant effects on starvation, malnutrition and mental health and well-being A successful response to this pandemic will therefore depend not just on top-down public-health interventions, but also uptake of cross-sectoral, culturally appropriate and locally-led approaches which translate high- level strategies derived not only from security, but also humanitarian and development agendas, into concrete policies and impactful activities on the ground.
    [Show full text]
  • UK in a Detailed, Qualitative Way, and Asks What Lessons They Hold for the Other Countries
    Research report July 2017 Learning from Scotland’s NHS Mark Dayan and Nigel Edwards About the report This is the first in a series of reports from the Trust that looks at each of the four health services of the UK in a detailed, qualitative way, and asks what lessons they hold for the other countries. It aims to identify how health care in Scotland is different, where its approach seems to solve problems being faced elsewhere in the UK, and whether that approach could be transplanted to England, Wales and Northern Ireland. Conversely, it assesses whether there are areas where Scotland could learn from its peers. The report arises initially from an event we held a year ago, in May 2016, at the Royal College of Physicians of Edinburgh, which invited 30 senior leaders and experts from Scottish health and care to discuss the country’s unique policies and institutions across quality improvement, workforce and integrated care. Key themes from the seminar were followed up in a series of interviews with 24 academics, health service managers and senior officials in Scotland between autumn 2016 and early 2017. Suggested citation Dayan M and Edwards N (2017), Learning from Scotland’s NHS. Research report. Nuffield Trust. Find out more online at: www.nuffieldtrust.org.uk/research Acknowledgements We would like to thank Professor Derek Bell of the Royal College of Physicians of Edinburgh for making the event that began this work possible; David Steel for all his vital work in looking over the report; Aoife McDermott for both her keynote address and her invaluable help in reviewing the report; Professor Jim McGoldrick and Rachel Cackett for their keynote addresses; Professor Alan Paterson, who spoke at the event; and all of our interviewees, listed in Appendix 3 on page 46, for their honesty and insight.
    [Show full text]
  • Speaker Biographies ASGBI’S International Surgical Congress
    ASGBI Association of Surgeons of O S M U N E M S A C AB IS O S D Great Britain and Ireland MNIBU Wednesday 3rd to Friday 5th May 2017, SEC, Glasgow Speaker Biographies ASGBI’s International Surgical Congress www.asgbi.org.uk/glasgow2017 - 1 - Mr Iain D Anderson ASGBI Vice President Iain Anderson has been Consultant Surgeon at Salford Royal Hospital, Manchester since 1995. He is a surgeon on the Intestinal Failure Unit, a national unit specialising in the treatment of intestinal fistulae and other complications after abdominal surgery. He trained in surgery in Manchester and Edinburgh and from 1994 developed and established the Care of the Critically Ill Surgical Patient (CCrISP) Course. From 2011, he was Director of Emergency Surgery at ASGBI, chairing or contributing to working groups on Emergency Surgical Care and Peri-operative Care of the Higher Risk Surgical Patient. Mr Tan Arulampalam Mr Tan Arulampalam qualified as a Doctor in 1992 from St Bartholomew’s Hospital (University of London). He completed his basic surgical training at St Bartholomew’s Hospital and was appointed to the higher surgical training scheme in London in 1996. After completion of his training he undertook a Fellowship with Professor Cristiano Hüscher in Rome and was appointed Consultant Laparoscopic GI Surgeon at Colchester General Hospital in November 2003. He has performed over 500 laparoscopic colorectal resections as well as a full range of advanced laparoscopic biliary, GI, emergency and hernia surgery. He is a Preceptor in Laparoscopic Colorectal Surgery for the Association of Laparoscopic Surgeons of Great Britain and Ireland.
    [Show full text]
  • The Psychology of COVID-19
    SAGE Publications Ltd Editorial Arrangement and Chapters 1-3 © Jolanda 1 Oliver’s Yard Jetten, Stephen D. Reicher, S. Alexander Haslam 55 City Road and Tegan Cruwys 2020. London EC1Y 1SP Chapter 4 © Niklas K. Steffens 2020, Chapter 5 © SAGE Publications Inc. Frank Mols 2020, Chapter 6 © Matthew J. Hornsey 2455 Teller Road 2020, Chapter 7 © Katharine H. Greenaway 2020, Thousand Oaks, California 91320 Chapter 8 © Tegan Cruwys 2020, Chapter 9 © Sarah V. Bentley 2020, Chapter 10 © Catherine SAGE Publications India Pvt Ltd Haslam 2020, Chapter 11 © Orla Muldoon 2020, B 1/I 1 Mohan Cooperative Industrial Area Chapter 12 © Fergus Neville & Stephen D. Reicher Mathura Road 2020, Chapter 13 © John Drury & Selin Tekin New Delhi 110 044 Guven 2020, Chapter 14 © Evangelos Ntontis & Carolina Rocha 2020, Chapter 15 © Holly Carter, SAGE Publications Asia-Pacific Pte Ltd Dale Weston & Richard Amlôt 2020, Chapter 16 © 3 Church Street Clifford Stott & Matt Radburn 2020, Chapter 17 © #10-04 Samsung Hub Jolanda Jetten 2020, Chapter 18 © Charlie R. Singapore 049483 Crimston & Hema Preya Selvanathan, Chapter 19 © Yuen J. Huo, Chapter 20 © John F. Dovidio, Elif G. Ikizer, Jonas R. Knust & Aharson Levy 2020. This ebook is free to download for personal use Editor: Amy Maher only. Please contact SAGE Publications if you wish to re-use any part of this ebook. Editorial assistant: Marc Barnard Apart from any fair dealing for the purposes of Marketing manager: Camille Richmond research or private study, or criticism or review, as permitted under the Copyright, Designs and Patents Cover design: Wendy Scott Act, 1988, this publication may be reproduced, stored or transmitted in any form, or by any means, only with the prior permission in writing of the publishers, or in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency.
    [Show full text]